Research

Josh Crossney is the columnist and editor of “Cannabis Crossroads” and a contributing editor to 

 magazine. Crossney is also the president and CEO of Cannabis Science Conference. Direct correspondence to:


Articles

AC Braddock, the CEO of Eden Labs, shares a preview of the talk she plans to give at Cannabis Science Conference West as well as other industry insights.

Sustainable Psychedelics: A Chat with CSC West Speaker, AC Braddock

Dr. Denise C. Vidot, an epidemiologist at the University of Miami and Founder of the International Cannabis & Psychedelic Research Collaborative, shares her research background, a small preview of her talk, “Co-Use of Cannabis and Psilocybin to Manage Mental Health Amid the COVID-19 Pandemic: Preliminary Results from the International COVID-19 Cannabis Health Study,” and more. 

Cannabis and Psychedelics Research: A Cannabis Science Conference West Preview with Dr. Denise Vidot

As time passes and more research comes to light regarding COVID-19, additional research is also needed for cannabis and its various cannabinoids.  Through new data, cannabis has shown that it has more to offer than the stigma it has been clouded by. In this interview, Inesa Ponomariovaite, founder of Nesas Hemp and a holistic health coach, discusses the untapped medicinal properties of cannabidiolic acid (CBDA) and cannabigerolic acid (CGBA) for COVID-19 prevention and treatment and why CBDA is the top cannabinoid.

CBDA and CBGA Promote Milder COVID-19 Symptoms Among Other Medicinal Health Benefits

In honor of International Women’s Day and Women’s History Month, we’re highlighting the talented female experts that will be presenting at the upcoming 2022 Cannabis Science Conference West on May 18-20 in Long Beach, California. 

Cannabis Science Conference Honors the Wisdom of Women

Let’s check back in with some of our top authors over the years to get their insight on how their articles resonated with readers and where the cannabis industry is headed.

High Five: Cannabis Science and Technology® Celebrates 5th Anniversary

Dr. Richard van Breemen from the Department of Pharmaceutical Sciences in the Oregon State University College of Pharmacy discusses his COVID-19 and cannabis research.

Cannabinoids and COVID-19: An Interview with Professor Richard van Breemen of Oregon State University

This study focuses on a step-by-step optimization of commercial scale preparative HPLC purification of cannabinoids, specifically cannabidiol, starting with stationary reversed-phase screening, followed by method optimization.

Development, Optimization, and Process Performance for Preparative Chromatographic Purification of Cannabinoids

It is demonstrated in this paper that cell viability can be used to determine dose and response effects that are important in understanding toxicities and to detect differences in similar hemp products.

Human Cells Can Be Used to Study Cannabinoid Dosage and Inflammatory Cytokine Responses

Results from a small, quantitative study conducted on behalf of Cannabis Science and Technology.

Cannabis Research Is Cannabis Science

A recent research study in the Journal of Nature Products showed that cannabis compounds prevented the COVID-19 virus from penetrating healthy human cells.